1. European Commission, SEC, 2007, 1635, available at .
2. World Health Organization, 2002, Global assessment of the state-of-the-science of endocrine disruptors, WHO/PCS/EDC/02.2, available at .
3. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders;Swedenborg;J. Mol. Endocrinol.,2009
4. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients;Agarwal;J. Clin. Endocrinol. Metab.,1996
5. Mechanisms in tissue-specific regulation of estrogen biosynthesis in human;Kamat;Trends Endocrinol. Metab.,2002